Effectiveness of a Wearable Hydration Device

Trial statusNot yet recruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age55+
SponsorMetroHealth Medical Center

About this trial

Dehydration among older adults a costs billions of dollars in US healthcare every year because no robust solution exists to detect changes in hydration and prevent negative outcomes. In this project, TritonX Technologies Inc. and academic research partners plan to test whether a newly created wearable sensor that measures hydration in real time can promote hydration and prevent the dehydration illnesses.

The investigators will conduct a randomized controlled trial to examine the effectiveness of continuous home monitoring of fluid levels in a cohort of vulnerable older adult patients seen in the emergency care setting.

The goal of this randomized control trial is to examine the effectiveness of continuous home monitoring of fluid levels in older patients presenting to the emergency department for dehydration. The main questions it aims to answer:

1. Can a wearable device accurately determine the severity of dehydration at home and 2. can a wearable device and continuous feedback from the device change behavior in the outpatient setting that can lead to improved outcomes in the treatment of dehydration in the elderly?

Investigators will compare device readings, hydration diaries, vital signs, blood samples, return visits to the emergency department, and to see if feedback from the device decreases signs and symptoms of dehydration and changes home management of dehydration.

Participants will be asked to:

* wear the device and monitor hydration status * record the amount of home hydration * return in 7-10 days for reassessment of dehydration

The successful outcome of this study will include evidence for the effectiveness of the home, wearable hydration monitoring device, data necessary for the FDA 510(k) and related regulatory processes and substantial enhancements to both our knowledge of older adult needs and device functionality.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

adult patients aged 55 and over

rresenting to the emergency department

clinical suspicion of dehydration

treatment of dehydration/syncope with fluid resuscitation

Disqualifiers

Refusal or inability to give informed consent,

severe clinical symptom requiring escalation of care beyond fluid resuscitation (ex. vasopressors, invasive blood pressure monitoring)

presumed/confirmed diagnosis of syncope secondary to a non-dehydration cause (ex. arrhythmia, stroke, pulmonary embolism, sepsis, valvular heart disease)

inability to lay flat for the test

Trial design

Design model

Parallel

Treatments tested in this trial

  • Device with Phone App

    Device

    This is the intervention where the patients will be given both the wearable dehydration device as well as the phone app

  • Device without Phone App

    Device

    This is the intervention where the patients will receive the device alone

Treatment groups

150 Participants
are divided into 2 treatment groups
Group A: Device with Interactive Phone AppActive comparator 1 intervention
Group B: Device without Interactive Phone APpSham comparator 1 intervention

Trial outcomes

Primary outcomes

1

Average daily fluid intake in mL

The average daily fluid intake over 10 days as determined by a standardized Drink Diary

Time frame
10 days

Secondary outcomes

1

Level of total body water after 10 days

Total body water after 10 days will be determined by the wearable dehydration device

Time frame
10 days
2

Midpoint Clinical symptoms of dehydration

Midpoint telehealth visit reports of syncope, dizziness, feeling of confusion, increased thirst, reported decreased urinary output, feeling fatigued

Time frame
5 days
3

End of Study Report of Dehydration

Any reported syncope, dizziness, feeling of confusion, increased thirst, reported decreased urinary output, feeling fatigued.

Time frame
10 days
4

End of Study Visit Heart Rate (beats per minute)

HR \>100 would be considered abnormal

Time frame
10 days

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

MetroHealth Medical Center

Lead sponsor

National Institute on Aging (NIA)

Collaborator

This trial is not recruiting at the moment. You can still explore other options: